Brucellosis is an endemic disease in Zimbabwe caused by the genus Brucella. Brucella seroprevalence was recently reported to be high in the wildlife-livestock interface in the Chiredzi district and the neighbouring Gonarezhou National Park (GNP) in Zimbabwe, and higher amongst communal cattle with an abortion history and access to grazing in GNP than amongst communal cattle with no abortion history or access to grazing in GNP. The aim of this study was to investigate Brucella species in brucellosis seropositive cattle in the Chiredzi district with access to GNP using isolation and identification. Isolation of Brucella species from whole blood (n = 18) and milk samples (n = 10) from seropositive animals with an abortion history was based on the rose Bengal test (RBT) and enzyme-linked immunoassays (enzyme- linked immunosorbent assay [ELISA]; indirect ELISA and complement ELISA), using microbiology and polymerase chain reaction (PCR) methods. Brucella abortus was cultured and identified from blood and milk collected from seropositive cows in both communal areas. The Brucella-specific 16-23S intergenic spacer (ITS) PCR and multiplex AMOS-PCR assays verified the identification of the cultures. Our results confirmed that B. abortus is present in cattle on communal farms in the Chiredzi district in Zimbabwe and might cause cattle abortions. The need for implementing control measures and raising public awareness on zoonotic transmission of brucellosis are recommended. (Résumé d'auteur)

Brucellosis is an endemic disease in Zimbabwe caused by the genus Brucella. Brucella seroprevalence was recently reported to be high in the wildlife-livestock interface in the Chiredzi district and the neighbouring Gonarezhou National Park (GNP) in Zimbabwe, and higher amongst communal cattle with an abortion history and access to grazing in GNP than amongst communal cattle with no abortion history or access to grazing in GNP. The aim of this study was to investigate Brucella species in brucellosis seropositive cattle in the Chiredzi district with access to GNP using isolation and identification. Isolation of Brucella species from whole blood (n = 18) and milk samples (n = 10) from seropositive animals with an abortion history was based on the rose Bengal test (RBT) and enzyme-linked immunoassays (enzyme- linked immunosorbent assay [ELISA]; indirect ELISA and complement ELISA), using microbiology and polymerase chain reaction (PCR) methods. Brucella abortus was cultured and identified from blood and milk collected from seropositive cows in both communal areas. The Brucella-specific 16-23S intergenic spacer (ITS) PCR and multiplex AMOS-PCR assays verified the identification of the cultures. Our results confirmed that B. abortus is present in cattle on communal farms in the Chiredzi district in Zimbabwe and might cause cattle abortions. The need for implementing control measures and raising public awareness on zoonotic transmission of brucellosis are recommended.

Brucellosis is an endemic disease in Zimbabwe caused by the genus <em>Brucella</em>. <em>Brucella</em> seroprevalence was recently reported to be high in the wildlife-livestock interface in the Chiredzi district and the neighbouring Gonarezhou National Park (GNP) in Zimbabwe, and higher amongst communal cattle with an abortion history and access to grazing in GNP than amongst communal cattle with no abortion history or access to grazing in GNP. The aim of this study was to investigate <em>Brucella</em> species in brucellosis seropositive cattle in the Chiredzi district with access to GNP using isolation and identification. Isolation of<em> Brucella </em>species from whole blood (<em>n</em> = 18) and milk samples (<em>n</em> = 10) from seropositive animals with an abortion history was based on the rose Bengal test (RBT) and enzyme-linked immunoassays (enzyme- linked immunosorbent assay [ELISA]; indirect ELISA and complement ELISA), using microbiology and polymerase chain reaction (PCR) methods. <em>Brucella abortus</em> was cultured and identified from blood and milk collected from seropositive cows in both communal areas. The<em> Brucella</em>-specific 16-23S intergenic spacer (ITS) PCR and multiplex AMOS-PCR assays verified the identification of the cultures. Our results confirmed that <em>B. abortus</em> is present in cattle on communal farms in the Chiredzi district in Zimbabwe and might cause cattle abortions. The need for implementing control measures and raising public awareness on zoonotic transmission of brucellosis are recommended.

estimates of glomerular filtration rate (GFR) in dogs with various degrees of renal function. Animals—50 Great Anglo-Francais Tricolor Hounds with various degrees of renal function. Procedures—Boluses of iohexol (40 mg/kg) and creatinine (647 mg/kg) were injected IV. Blood samples were collected before administration and 5 and 10 minutes and 1, 2, 4, 6, and 8 hours after administration. Plasma creatinine and iohexol concentrations were assayed via an enzymatic method and high-performance liquid chromatography, respectively. A noncompartmental approach was used for pharmacokinetic analysis. Pharmacokinetic variables were compared via a Bland-Altman plot and an ANOVA. Results—Compared with results for creatinine, iohexol had a significantly higher mean ± SD plasma clearance (3.4 ± 0.8 mL/min/kg vs 3.0 ± 0.7 mL/min/kg) and a significantly lower mean volume of distribution at steady state (250 ± 37 mL/kg vs 539 ± 73 mL/kg), mean residence time (80 ± 31 minutes vs 195 ± 73 minutes), and mean elimination half-life (74 ± 20 minutes vs 173 ± 53 minutes). Despite discrepancies between clearances, especially for high values, the difference was < 0.6 mL/min/kg for 34 (68%) dogs. Three dogs with a low GFR (< 2 mL/min/kg) were classified similarly by both methods. Conclusions and Clinical Relevance—Plasma iohexol and creatinine clearances can be used interchangeably for screening patients suspected of having chronic kidney disease (ie, low GFR), but large differences may exist for dogs with a GFR within or above the reference range. (Am J Vet Res 2012;73:1841–1847)

Objective: To compare pharmacokinetics and clearances of creatinine and iohexol as estimates of glomerular filtration rate (GFR) in dogs with various degrees of renal function. Animals: 50 Great Anglo-Francais Tricolor Hounds with various degrees of renal function. Procedures: Boluses of iohexol (40 mg/kg) and creatinine (647 mg/kg) were injected IV. Blood samples were collected before administration and 5 and 10 minutes and 1, 2, 4, 6, and 8 hours after administration. Plasma creatinine and iohexol concentrations were assayed via an enzymatic method and high-performance liquid chromatography, respectively. A noncompartmental approach was used for pharmacokinetic analysis. Pharmacokinetic variables were compared via a Bland-Altman plot and an ANOVA. Results: Compared with results for creatinine, iohexol had a significantly higher mean ± SD plasma clearance (3.4 ± 0.8 mL/min/kg vs 3.0 ± 0.7 mL/min/kg) and a significantly lower mean volume of distribution at steady state (250 ± 37 mL/kg vs 539 ± 73 mL/kg), mean residence time (80 ± 31 minutes vs 195 ± 73 minutes), and mean elimination half-life (74 ± 20 minutes vs 173 ± 53 minutes). Despite discrepancies between clearances, especially for high values, the difference was < 0.6 mL/min/kg for 34 (68%) dogs. Three dogs with a low GFR (< 2 mL/min/kg) were classified similarly by both methods. Conclusions and Clinical Relevance: Plasma iohexol and creatinine clearances can be used interchangeably for screening patients suspected of having chronic kidney disease (ie, low GFR), but large differences may exist for dogs with a GFR within or above the reference range.

peer reviewed

Objective: To assess long-term effects and risk factors for the efficacy of hyperimmunization protocols against infectious bovine rhinotracheitis (IBR) during a longitudinal field study of dairy and dairy-beef mixed farms. Animals: Approximately 7,700 cows from 72 farms. Procedures: Farms were assigned to 3 treatment groups (hyperimmunization groups [HIGs] 1 and 2, which were hyperimmunized with glycoprotein E [gE]–deleted marker vaccines, and a nonintervention group [NIG]). Cattle in HIG 1 were initially vaccinated with an attenuated vaccine, whereas cattle in HIG 2 were initially vaccinated with an inactivated-virus vaccine. Cattle in both HIGs received booster inoculations with inactivated-virus vaccines at 6-month intervals. The risk for gE seroconversion was compared among experimental groups via a shared frailty model with a piecewise constant baseline risk to correct for seasonal and secular effects. Results: Risk for gE seroconversion significantly decreased over time for the HIGs, compared with the NIG. Seasonal changes in the risk of gE seroconversion were detected, with a higher risk during winter periods, compared with grazing periods. No significant difference was detected between HIGs 1 and 2. The only significant risk factor was the number of buildings for cattle on a farm; the higher the number of buildings, the lower the risk for gE seroconversion. Prevalence of IBR decreased over time in both HIGs but remained constant or increased in the NIG. Conclusions and Clinical Relevance: Hyperimmunization via repeated administration of attenuated and inactivated-virus gE-deleted marker vaccines as well as inactivated-virus vaccines may provide a method for control of IBR.

O objetivo deste estudo foi avaliar os fosfatos de cálcio, pirofosfato de cálcio (CPP) com tratamento térmico a 700 e 900°C, fosfato tricálcio associado à hidroxiapatita (TCP/HA) e hidroxiapatita (HA) como substitutos ósseos. Foram utilizados 20 coelhos (Oryctolagus cuniculus), de ambos os sexos, da raça Nova Zelândia, pesando em média 2,5±0,41kg. Os animais foram distribuídos, ao acaso, em dois grupos de 10 animais de acordo com o período em que foram eutanasiados (30 ou 60 dias). Os implantes foram introduzidos na metáfise proximal e distal de cada fêmur, de modo que os CPP 700 e 900 foram introduzidos no membro esquerdo, enquanto o TCP/HA e HA no membro direito. Foram realizadas avaliações clínico-cirúrgicas e radiográficas imediatamente após a cirurgia e aos 30 e 60 dias do pós-operatório. Os animais apresentaram evolução clínica normal. Na avaliação radiográfica observou-se diferença estatística entre os grupos com maior grau de radiopacidade nos animais do grupo 60 dias que utilizaram os implantes TCP/HA e HA. Na avaliação histológica, por meio de microscopia de luz e análise morfométrica, os materiais TCP/HA e HA proporcionaram maior neoformação óssea ao redor dos implantes do que com os CPP700 e CPP900 aos 30 e 60 dias de avaliação. | The aim of this study was to evaluate the calcium phosphate, calcium pyrophosphate (CPP) with heat treatment at 700 and 900 ° C, tricalcium phosphate combined with hydroxyapatite (TCP/HA) and hydroxyapatite (HA) as bone substitutes. We used 20 rabbits (Oryctolagus cuniculus) of both sexes, New Zealand breed, with mean weigh of 2.5 ± 0.41 kg. The animals were randomly divided into two groups of 10 animals in the period in which they were euthanized (30 or 60 days). The implants were placed on the proximal and distal metaphysis of each femur so that CPP 700 and 900 were introduced in the left, while TCP/HA and HA in the right. Clinical and radiographic-surgical evaluations were performed immediately after surgery, and 30 and 60 days post-surgery. The animals showed normal clinical evolution. In the radiographic evaluation there was statistical difference between groups with higher degree of radiopacity at group 60 days that used TCP/HA and HA implants. In the histological evaluation by light microscopy and morphometric analysis the materials TCP/HA and HA showed greater one formation around the implants than CPP700 and CPP900 at 30 and 60-days evaluation.

O objetivo deste estudo foi avaliar os fosfatos de cálcio, pirofosfato de cálcio (CPP) com tratamento térmico a 700 e 900°C, fosfato tricálcio associado à hidroxiapatita (TCP/HA) e hidroxiapatita (HA) como substitutos ósseos. Foram utilizados 20 coelhos (Oryctolagus cuniculus), de ambos os sexos, da raça Nova Zelândia, pesando em média 2,5±0,41kg. Os animais foram distribuídos, ao acaso, em dois grupos de 10 animais de acordo com o período em que foram eutanasiados (30 ou 60 dias). Os implantes foram introduzidos na metáfise proximal e distal de cada fêmur, de modo que os CPP 700 e 900 foram introduzidos no membro esquerdo, enquanto o TCP/HA e HA no membro direito. Foram realizadas avaliações clínico-cirúrgicas e radiográficas imediatamente após a cirurgia e aos 30 e 60 dias do pós-operatório. Os animais apresentaram evolução clínica normal. Na avaliação radiográfica observou-se diferença estatística entre os grupos com maior grau de radiopacidade nos animais do grupo 60 dias que utilizaram os implantes TCP/HA e HA. Na avaliação histológica, por meio de microscopia de luz e análise morfométrica, os materiais TCP/HA e HA proporcionaram maior neoformação óssea ao redor dos implantes do que com os CPP700 e CPP900 aos 30 e 60 dias de avaliação.

Dentre os problemas que diminuem a eficiência reprodutiva em rebanhos leiteiros a falha de detecção de estro é um dos fatores mais importantes. Objetivou-se avaliar a eficiência de um dispositivo que auxilia a detecção de estros – Estrotect® e compará-lo com a detecção visual em 58 vacas mestiças leiteiras Holandês/Gir com produção média de 18,5 kg de leite/dia/vaca. Os animais foram distribuídos em dois grupos: o grupo IATF (n= 21) foi submetido a um protocolo de inseminação artificial em tempo fixo (IATF) e 10 dias após a inseminação foi fixado o dispositivo nos animais. No grupo PG (n=37), foi administrado prostaglandina 25mg/animal/IM e imediatamente colado o adesivo. Essas vacas foram monitoradas por meio de exame ultrassonográfico num período de 28 dias para verificação do desenvolvimento do corpo lúteo. Para verificar se ocorreram alterações na eficiência do dispositivo quanto aos grupos utilizou-se a regressão logística e para comparar a eficiência do mesmo em relação à observação visual utilizou-se o teste de MCNemar. Não foi detectado efeito de grupo (P&gt;0,05) na eficiência da detecção visual de estro ou da ferramenta auxiliar. Também não foi detectada diferença entre a eficiência da detecção visual de estro e o dispositivo (P&gt;0,05). A ferramenta auxiliar de detecção de estro (Estrotect®) se mostrou tão eficiente quanto a detecção visual e pode ser utilizada em programas de inseminação artificial de vacas leiteiras. | Among the problems that reduce the reproductive efficiency in dairy cows the failure in estrus detection is a major factor. The objective of this study was to evaluate the efficiency of Estrotect®, a device that aids heat detection in cattle, and to compare it with visual detection in 58 crossbred Holstein/Gyr dairy cows producing 18.5Kg/milk/cow. The animals were divided into two groups: the TAI (n = 21) underwent a fixed-time artificial insemination protocol (TAI), and 10 days after insemination, the device was fixed to the cows. In the PG group (n = 37) prostaglandin (dinoprost tromethamine) 25mg/animal/IM was administered, and then the device was put in place. These cows were then monitored by ultrasound over a period of 28 days to verify the development of the corpus luteum. Logistic regression was used to find out if there were alterations in the efficiency of Estrotect® within the groups, and the McNemar test was used to compare its efficiency to that of visual observation. No group effect was detected (P&gt; 0.05) on the efficiency of visual detection nor on that of the auxiliary device. Neither was there observed any difference between the efficiency of visual detection of estrus and that of the device (P&gt; 0.05). The auxiliary tool for the detection of estrus, (Estrotect ®), proved to be just as effective as visual detection. Thus, it can be used as an auxiliary device in conjunction with visual observation, and also as a unique tool for the detection of estrus in order to simplify the management of large herds.

Dentre os problemas que diminuem a eficiência reprodutiva em rebanhos leiteiros a falha de detecção de estro é um dos fatores mais importantes. Objetivou-se avaliar a eficiência de um dispositivo que auxilia a detecção de estros – Estrotect® e compará-lo com a detecção visual em 58 vacas mestiças leiteiras Holandês/Gir com produção média de 18,5 kg de leite/dia/vaca. Os animais foram distribuídos em dois grupos: o grupo IATF (n= 21) foi submetido a um protocolo de inseminação artificial em tempo fixo (IATF) e 10 dias após a inseminação foi fixado o dispositivo nos animais. No grupo PG (n=37), foi administrado prostaglandina 25mg/animal/IM e imediatamente colado o adesivo. Essas vacas foram monitoradas por meio de exame ultrassonográfico num período de 28 dias para verificação do desenvolvimento do corpo lúteo. Para verificar se ocorreram alterações na eficiência do dispositivo quanto aos grupos utilizou-se a regressão logística e para comparar a eficiência do mesmo em relação à observação visual utilizou-se o teste de MCNemar. Não foi detectado efeito de grupo (P>0,05) na eficiência da detecção visual de estro ou da ferramenta auxiliar. Também não foi detectada diferença entre a eficiência da detecção visual de estro e o dispositivo (P>0,05). A ferramenta auxiliar de detecção de estro (Estrotect®) se mostrou tão eficiente quanto a detecção visual e pode ser utilizada em programas de inseminação artificial de vacas leiteiras.

A administração isolada de xilazina (XIL) e acepromazina (ACP) pode diminuir o hematócrito (HT) de equinos. Na rotina anestésica, estes fármacos são administrados em associações, cujo efeito final no HT não é conhecido, mas pode causar falsas impressões sobre o grau de hidratação, perda sanguínea e índices hematimétricos. O objetivo deste estudo foi caracterizar os valores de HT de equinos anestesiados com XYL, ACP, cetamina, midazolam, EGG, isofluorano e efedrina. Vinte equinos hígidos foram pré-tratados com XIL 0,8 mg/kg (grupo XIL, n=10) ou XIL 0,5 mg/kg associada à ACP 0,05 mg/kg (grupo XIL+ACP, n=10). A anestesia foi induzida com cetamina, midazolam e EGG e mantida com isofluorano. A efedrina foi utilizada para suporte cardiovascular. O HT, parâmetros vitais e hemogasometria foram avaliados no momento basal, entre administração de cada fármaco, após retorno à posição quadrupedal e 24 horas após momento basal (24hBL). A diminuição do HT iniciou-se 17 e 40 minutos após administração da medicação préanestésica no grupo XIL e grupo XIL+ACP, respectivamente (p&lt;0,05). A queda máxima de 19% no grupo XIL e 17% no grupo XIL+ACP foi observada após 1 hora da administração da medicação pré-anestésica (p&lt;0,05). Em ambos os grupos, o HT permaneceu baixo por mais de 180 minutos e retornou aos valores basais em 24hBL. Deve-se considerar a ocorrência de uma redução significativa do HT em equinos hígidos anestesiados com XYL, ACP, cetamina, midazolam, EGG, isofluorano e efedrina. | Xylazine (XYL) and acepromazine (ACP) are known to decrease the hematocrit (HT) of horses when administered alone. However in routine anesthesia these drugs are administered by associations which ultimate effect in the HT is unknown but may cause false impressions about the hydration status, blood loss and red blood cell indices. The objective of this study was to characterize the values of HT in horses anesthetized with XYL, ACP, ketamine, midazolam, guaiphenesin, isoflurane and ephedrine. Twenty healthy horses were premedicated with either XYL 0.8 mg/kg (XYL group, n=10) or XYL 0.5 mg/kg plus ACP 0.05 mg/kg (XYL+ACP group, n=10). Anesthesia was induced with ketamine, midazolam and guaiphenesin and maintained with isoflurane. Ephedrine was infused for cardiovascular support. HT, vital parameters and blood gas values were evaluated at baseline, between each drug administration, after standing and 24 hours after baseline (24hBL). The HT started to decrease 17 and 40 minutes after premedication in XYL group and XYL+ACP group, respectively (p&lt;0.05). The maximum decrease of 19% in XYL group and 17% in XYL+ACP group was observed after 1 hour of premedication (p&lt;0.05). In both groups HT remained low for longer than 180 minutes and returned to baseline at 24hBL. A significant HT decrease should be considered in anesthetized healthy horses receiving XYL, ACP, ketamine, midazolam, guaiphenesin, isoflurane and ephedrine.

A administração isolada de xilazina (XIL) e acepromazina (ACP) pode diminuir o hematócrito (HT) de equinos. Na rotina anestésica, estes fármacos são administrados em associações, cujo efeito final no HT não é conhecido, mas pode causar falsas impressões sobre o grau de hidratação, perda sanguínea e índices hematimétricos. O objetivo deste estudo foi caracterizar os valores de HT de equinos anestesiados com XYL, ACP, cetamina, midazolam, EGG, isofluorano e efedrina. Vinte equinos hígidos foram pré-tratados com XIL 0,8 mg/kg (grupo XIL, n=10) ou XIL 0,5 mg/kg associada à ACP 0,05 mg/kg (grupo XIL+ACP, n=10). A anestesia foi induzida com cetamina, midazolam e EGG e mantida com isofluorano. A efedrina foi utilizada para suporte cardiovascular. O HT, parâmetros vitais e hemogasometria foram avaliados no momento basal, entre administração de cada fármaco, após retorno à posição quadrupedal e 24 horas após momento basal (24hBL). A diminuição do HT iniciou-se 17 e 40 minutos após administração da medicação préanestésica no grupo XIL e grupo XIL+ACP, respectivamente (p<0,05). A queda máxima de 19% no grupo XIL e 17% no grupo XIL+ACP foi observada após 1 hora da administração da medicação pré-anestésica (p<0,05). Em ambos os grupos, o HT permaneceu baixo por mais de 180 minutos e retornou aos valores basais em 24hBL. Deve-se considerar a ocorrência de uma redução significativa do HT em equinos hígidos anestesiados com XYL, ACP, cetamina, midazolam, EGG, isofluorano e efedrina.